JSS-ICOM Medical Research offers a complete body of functional capabilities across the entire drug development lifecycle. In addition to clinical trials required for regulatory submission, JSS Medical Research especially excels in conducting post-approval studies to generate real-life data.
Our services can help biotechnology, pharmaceutical, medical device & nutraceutical firms achieve their clinical research program goals leading to regulatory submission for marketing approval. Once approved for market, JSS Medical Research expertise in Phase IV studies, PMOS and Administrative Database/Registry analysis can help companies further generate strong real-life evidence to support, confirm or expand clinical trial results. In an increasing complex market access environment, a good value proposition with appealing data is the first cornerstone to gaining or supporting reimbursement.